Ads
related to: lupus treatment- Sign Up Today
Sign Up To Receive Information &
Resources For A Treatment Option.
- Learn How It Works
Discover How A Lupus Treatment
Option Works.
- Savings Program
Review Eligibility For A
Treatment Option's Savings Program.
- Patient Support Programs
Find Out What Patient Support
Programs Are Available To You.
- Sign Up Today
Search results
Nisa Investment Advisors LLC Buys 3,847 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS)
ETF DAILY NEWS· 3 days agoNisa Investment Advisors LLC raised its stake in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) by 7,258.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund ...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Given Average Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 5 days agoShares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eleven brokerages that are covering the firm, Marketbeat ...
Cartesian Therapeutics’ (RNAC) “Outperform” Rating Reiterated at Leerink Partnrs
ETF DAILY NEWS· 2 days agoLeerink Partnrs reissued their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a research report report published on Tuesday morning, Zacks.com reports.
Q2 2024 EPS Estimates for argenx SE (NASDAQ:ARGX) Lifted by Analyst
ETF DAILY NEWS· 2 days agoWilliam Blair analyst M. Minter now expects that the company will post earnings per share of ($0.83) for the quarter, up from their prior forecast of ($1.03). The consensus estimate for argenx’s current full-year earnings is ($2.10) per share.
SG Americas Securities LLC Has $57,000 Stake in Nektar Therapeutics (NASDAQ:NKTR)
ETF DAILY NEWS· 4 days agoSG Americas Securities LLC lifted its holdings in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 30.6% during the 4th quarter, according to its most recent filing with the Securities and ...
MorphoSys AG (NASDAQ:MOR) Given Consensus Rating of “Hold” by Analysts
ETF DAILY NEWS· 24 hours agoMorphoSys AG (NASDAQ:MOR – Get Free Report) has been given an average rating of “Hold” by the eight analysts that are covering the stock, Marketbeat.com reports. Five investment analysts have ...
Brokerages Set argenx SE (NASDAQ:ARGX) PT at $530.74
ETF DAILY NEWS· 6 days agoOne investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, fourteen have given a buy recommendation and one has assigned a strong buy recommendation ...
Handelsbanken Fonder AB Has $9.84 Million Position in argenx SE (NASDAQ:ARGX)
ETF DAILY NEWS· 20 hours agoHandelsbanken Fonder AB reduced its stake in argenx SE (NASDAQ:ARGX – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned ...
William Blair Weighs in on argenx SE’s Q1 2024 Earnings (NASDAQ:ARGX)
ETF DAILY NEWS· 5 days agoWilliam Blair analyst M. Minter now anticipates that the company will earn ($0.89) per share for the quarter, up from their previous forecast of ($1.24). The consensus estimate for argenx’s current full-year earnings is ($2.10) per share.
argenx (NASDAQ:ARGX) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 6 days agoargenx (NASDAQ:ARGX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report issued on Thursday, Benzinga reports. They presently have a ...
Ads
related to: lupus treatment